financetom
Business
financetom
/
Business
/
Gannett Shares Slightly Down After Q3 Loss Widens, Revenue Falls; Announces AI Licensing Deal With Microsoft
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gannett Shares Slightly Down After Q3 Loss Widens, Revenue Falls; Announces AI Licensing Deal With Microsoft
Oct 30, 2025 8:26 AM

11:10 AM EDT, 10/30/2025 (MT Newswires) -- Gannett ( GCI ) shares were slightly lower in recent Thursday trading after it reported a wider loss and lower revenue in Q3, while announcing an artificial intelligence licensing agreement with Microsoft ( MSFT ) .

The newspaper publisher earlier posted a Q3 net loss of $0.27 per diluted share, widening from a loss of $0.14 a year earlier.

An analyst polled by FactSet expected a loss of $0.09.

Revenue for the quarter ended Sept. 30 was $560.8 million, down from $612.4 million a year earlier.

Four analysts surveyed by FactSet expected $571 million.

On a same-store basis, Gannett ( GCI ) continues to expect 2025 revenue to be down in the low-mid single digits.

Gannett ( GCI ) Chairman and Chief Executive Michael Reed announced the company's newest AI licensing deal, under which it is collaborating with Microsoft ( MSFT ) on the launch of Publisher Content Marketplace. Financial terms weren't provided.

Price: 4.09, Change: -0.02, Percent Change: -0.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SAGE Therapeutics Says Study Unable to Show Meaningful Difference in Participants Treated With Dalzanemdor Versus Placebo
SAGE Therapeutics Says Study Unable to Show Meaningful Difference in Participants Treated With Dalzanemdor Versus Placebo
Oct 10, 2024
07:15 AM EDT, 10/08/2024 (MT Newswires) -- SAGE Therapeutics ( SAGE ) said Tuesday that topline results from its phase 2 LIGHTWAVE study for the treatment of mild cognitive impairment or mild dementia due to Alzheimer's disease did not demonstrate a statistically significant difference in dalzanemdor-treated participants versus placebo. As a result, the company said it does not plan further...
Honeywell Seeks To Simplify Structure, Boost Flexibility With $10B Spin-Off Of Advanced Materials Unit
Honeywell Seeks To Simplify Structure, Boost Flexibility With $10B Spin-Off Of Advanced Materials Unit
Oct 10, 2024
On Tuesday, diversified manufacturing and technology company Honeywell International ( HON ) announced its plan to spin off its Advanced Materials business into an independent, U.S. publicly traded company. The Wall Street Journal first reported the tax-free separation. “Through the powerful combination of strategic bolt-on acquisitions and subtractions of high quality but non-core business lines, we continue to enhance our...
Berkshire Hathaway Further Pares Bank of America Stake
Berkshire Hathaway Further Pares Bank of America Stake
Oct 10, 2024
07:10 AM EDT, 10/08/2024 (MT Newswires) -- Berkshire Hathaway (BRK.A, BRK.B) sold an additional 9.6 million common shares of Bank of America ( BAC ) in three transactions, according to a filing late Monday. The filing showed that Berkshire Hathaway sold 302,604 common shares of Bank of America ( BAC ) at $39.25 apiece last Thursday, 5.2 million shares at...
India warns Ola Electric on customer service after 10,000 complaints
India warns Ola Electric on customer service after 10,000 complaints
Oct 10, 2024
By Aditya Kalra NEW DELHI, Oct 8 (Reuters) - India's consumer rights agency received unusually high 10,000 complaints against Ola Electric over a year and has sent a notice seeking explanation from the SoftBank-backed e-scooter maker, a top official at the watchdog said on Tuesday. Following a stellar market debut in August, shares in India's biggest e-scooter maker have fallen...
Copyright 2023-2026 - www.financetom.com All Rights Reserved